Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 20,021 shares at $7.97 ($160K) on 2021-02-02, disclosed to the SEC on 2021-02-03.
Open-market sale of $160k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.97 | 1,959 | $16K | 9.8% |
| 2 | $7.97 | 9,031 | $72K | 45.1% |
| 3 | $7.97 | 9,031 | $72K | 45.1% |
| Total | $7.97 avg | 20,021 | $160K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |